HYUNDAI:NSEHyundai Motor India Limited Analysis
Data as of 2026-08-01 - not real-time
₹2,180.70
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hyundai Motor India is trading just below its recent resistance level with the RSI firmly in overbought territory, suggesting short‑term pressure may build. The MACD remains bullish and volume is on the rise, but the neutral trend direction and proximity to the resistance ceiling temper enthusiasm for immediate upside.
Fundamentally, the company carries a high price‑to‑earnings multiple and an elevated price‑to‑book ratio, while dividend yield is modest and payout is comfortably covered by cash reserves. Low beta indicates limited market‑wide volatility, yet the sector’s consumer‑cyclical nature and a modest revenue decline add a layer of cyclical risk. Overall, the stock appears overvalued in the near term but retains a longer‑run case on earnings growth expectations and a sustainable dividend.
Fundamentally, the company carries a high price‑to‑earnings multiple and an elevated price‑to‑book ratio, while dividend yield is modest and payout is comfortably covered by cash reserves. Low beta indicates limited market‑wide volatility, yet the sector’s consumer‑cyclical nature and a modest revenue decline add a layer of cyclical risk. Overall, the stock appears overvalued in the near term but retains a longer‑run case on earnings growth expectations and a sustainable dividend.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI indicating overbought conditions
- Price approaching recent resistance
- Neutral trend despite bullish MACD
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward earnings growth expectations
- Low beta and increasing volume support stability
- Sustainable dividend with ample cash balance
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential upside from EV and SUV portfolio expansion
- Long‑run earnings upside offsetting current valuation premium
- Resilient balance sheet with modest debt
Key Metrics & Analysis
Financial Health
Revenue Growth-0.50%
Profit Margin7.00%
P/E Ratio35.8
Debt/Equity5.48
P/B Ratio8.9
Technical Analysis
TrendNeutral
RSI73.3
Support₹1,895.40
Resistance₹2,208.00
MA 20₹1,987.50
MA 50₹1,955.56
MA 200₹2,095.19
MACDBullish
VolumeIncreasing
Fear & Greed Index92.88
Valuation
Target Price₹2,253.88
Upside/Downside3.36%
GradeOvervalued
TypeBlend
Dividend Yield0.96%
Risk Assessment
Beta0.42
Volatility33.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.